Dan Gilbert's son, Nick, passed away in 2023 after a prolonged struggle with neurofibromatosis (NF), a rare genetic disorder that leads to tumor growth on nerve tissues. Despite the family's extensive medical resources, they were unable to halt the progression of the disease, which ultimately affected Nick's ability to communicate and led to his death.
In response to this tragedy, Gilbert has committed to honoring his son's legacy by focusing on finding a cure for NF through the Gilbert Family Foundation. The foundation has raised significant funds, including $12 million in a single event, and has partnered with the Children's Tumor Foundation to support NF research.
Gilbert's involvement has been crucial in advancing treatments, with two FDA-approved therapies now available for inoperable NF tumors. His determination to combat this disease reflects a broader trend where personal experiences drive philanthropic initiatives, potentially influencing investor perceptions of corporate leaders who prioritize social causes alongside business success